Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients
NCT05859932 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-05-16
Summary
The percentages of participants in clinical studies haven't always been perfectly representative of a particular group.
This research examines the variables that affect a patient's choice to enroll in, discontinue participation in, or resume participation in a clinical trial for hairy cell leukemia.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of hairy cell leukemia studies.
Conditions
- Hairy Cell Leukemia
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-30
- Primary Completion
- 2025-06-30
- Completion
- 2026-06-30
More Related Trials
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Delving Into Participation Trends in Renal Cell Carcinoma Studies
NCT06093568 ·Status: NOT_YET_RECRUITING
-
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01520246 ·Status: COMPLETED
-
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
NCT01139333 ·Status: COMPLETED
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
NCT00899496 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
NCT05588154 ·Status: RECRUITING
-
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882
NCT00898469 ·Status: COMPLETED
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Registry of the German CLL Study Group
NCT02863692 ·Status: RECRUITING
-
Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells
NCT01286883 ·Status: TERMINATED
-
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
NCT00904514 ·Status: TERMINATED
-
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
NCT05587439 ·Status: RECRUITING
-
Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients
NCT07162532 ·Status: NOT_YET_RECRUITING
-
Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
NCT01221766 ·Status: COMPLETED
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 ·Status: RECRUITING
-
Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery
NCT02579551 ·Status: COMPLETED ·Phase: NA
-
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
NCT00898079 ·Status: COMPLETED
-
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
NCT00918658 ·Status: TERMINATED
-
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
NCT01057095 ·Status: COMPLETED
-
Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy
NCT01869218 ·Status: COMPLETED
-
Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients
NCT02111031 ·Status: WITHDRAWN
-
Study of Specimens From Young Patients With Neuroblastoma
NCT00958659 ·Status: COMPLETED
-
A Clinical Study to Determine Biomarkers of Response to a Gamma Secretase Inhibitor
NCT00803894 ·Status: COMPLETED ·Phase: PHASE1